Simple approach to improving vancomycin dosing in intensive care: A standardised loading dose results in earlier therapeutic levels

Internal Medicine Journal

Volumn 42, Issue 1, 2012, Pages 23-29

  Truong, J ^a   Levkovich, B J ^a   Padiglione, A A ^b  

^a Alfred Health   (Australia)

^b Lab of Infectious Diseases   (Australia)

Author keywords

Anti bacterial agent; Drug dosage calculation; Drug monitoring; Intensive care; Vancomycin

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ARTICLE; AWARENESS; CREATININE CLEARANCE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; INTERVENTION STUDY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL PATIENT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BURNS; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MEDICAL AUDIT; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; STANDARD OF CARE; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; VICTORIA;

EID: 84856248934     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02459.x     Document Type: Article

References (18)

1. Moise PA, Forrest A, Bhavnani SM, Birmingham MC, Shentag JJ. Area under the inhibitory curve and pneumonia scoring system for predicting outcome of vancomycin therapy for respiratory infections by Staphylococcus aureus. Am J Health Syst Pharm 2000; 57: S4-S9.
2. Howden BP, Ward PB, Johnson PDR, Charles PGP, Grayson ML. Low-level vancomycin resistance in Staphylococcus aureus - an Australian perspective. Eur J Clin Microbiol Infect Dis 2005; 24: 100-8.
3. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Impact of shock and inappropriate antibiotics therapy on survival. Chest 2003; 123: 1615-24.
4. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S etal. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-96.
5. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
6. Rybak M, Lomaestro B, Rotschafer JC, Moellering JR, Craig W, Billeter M etal. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm 2009; 66: 82-98.
7. Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients. Clin Pharmacokinet 2005; 44: 1009-34.
8. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37: 840-51.
9. Wada DR, Drover DR, Lemmens HJ. Determination of the distribution volume that can be used to calculate the intravenous loading dose. Clin Pharmacokinet 1998; 35: 1-7.
10. Pea F, Viale P. Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycn? Clin Pharmacokinet 2008; 47: 147-52.
11. Gilbert DN, Moellering JRC, Eliopoulos GM, Sande MA, eds. The Sandford Guide to Antimicrobial Therapy, 37th edn. Hyde Park, VT: Antimicrobial Therapy Inc.; 2007.
12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004; 8: R204-R212.
13. Kitzis MD, Goldstein FW. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Clin Microbiol Infect 2006; 12: 92-5.
14. Mohammedi I, Descloux E, Argaud L, Le Scanff J, Robert D. Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500mg. Int J Antimicrob Agents 2006; 27: 259-62.
15. Wang JT, Fang CT, Chen YC, Chang SC. Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother 2001; 47: 246.
16. DelDot ME, Lipman J, Tett SE. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. Br J Clin Pharmacol 2004; 58: 259-68.
17. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009; 49: 507-14.
18. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-69.